TUBE1 and hepatocellular carcinoma: While the downregulation of TUBE1 in HCC has been previously reported [49], current results with SVM-RFE and RF-RFE were the first to suggest the potential utility of TUBE1 as a diagnostic biomarker and highlight the role for TUBE1 in distinguishing HCC from normal tissue.